![The Selective Estrogen Receptor Modulator DT56a...](Upload/202108/news_2021082710422102.png?1722066338)
The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women
Objective: The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on platelet function in normal and thrombophilic women being treated for severe menopausal symptoms.
Menopause: The Journal of The North American Menopause Society Vol. 18, No. 3, pp. 285/288
![The Selective Estrogen Receptor Modulator DT56a...](Upload/202202/news_2022020715150603.jpg?1722066338)